Civil Litigation
Sep. 30, 2019
Latest Monsanto dispute concerns expert testimony
Monsanto Co. is trying to improperly change its strategy midstream in the federal Roundup cases by trying to admit new experts and opinions in forthcoming trials, argued attorneys representing nearly 2,000 cancer-stricken people on Friday. After three losses, the Bayer AG-owned company maintained it is simply refining its defense, according to court filings.




Monsanto Co. is trying to improperly change its strategy midstream in the federal Roundup cases by trying to admit new experts and opinions in forthcoming trials, argued attorneys representing nearly 2,000 cancer-stricken people on Friday.
After three losses, the Bayer AG-owned company maintained it is simply refining its defense, according to court filings. It accused the other side of employing an "explicit, strategic gambit" to ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In